Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition
Authors:
- Debora D. MerrillDMDebora D. Merrill
- Harry A. GuessHGHarry A. Guess
- Peter J. RoylancePRPeter J. Roylance
- Warren D. CooperWCWarren D. Cooper
- William H. W. InmanWIWilliam H. W. Inman
- Pamela W. EwanPEPamela W. Ewan
- 19 August 1988
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 260 (7) , 967-970
Abstract
Research from JAMA — Clinical Profile of Angioedema Associated With Angiotensin Converting-Enzyme InhibitionKeywords
This publication has 9 references indexed in Scilit:
- Effects of intradermal bradykinin after inhibition of angiotensin converting enzyme.BMJ, 1987
- EXACT BINOMIAL CONFIDENCE INTERVALS FOR THE RELATIVE RISK IN FOLLOW-UP STUDIES WITH SPARSELY STRATIFIED INCIDENCE DENSITY DATA1American Journal of Epidemiology, 1987
- Ulcerogenicity of piroxicam: an analysis of spontaneously reported data.BMJ, 1987
- Effect of enalapril on the skin response to bradykinin in man.British Journal of Clinical Pharmacology, 1987
- Effect of vasoactive peptides on prostacyclin synthesis in manBritish Journal of Pharmacology, 1986
- A new class of angiotensin-converting enzyme inhibitorsNature, 1980
- Familial Carboxypeptidase N DeficiencyAnnals of Internal Medicine, 1980
- A biochemical abnormality in hereditary angioneurotic edemaThe American Journal of Medicine, 1963
- HEREDITARY ANGIO-NEUROTIC ŒDEMAThe American Journal of the Medical Sciences, 1888